Claudia Giani, MD

Medical Doctor
Fondazione IRCCS Istituto Nazionale Tumori, Italy

From September 2013 to September 2019 School of Medicine and Surgery, University of Milano-Bicocca: degree in Medicine and Surgery.
From August 2018 to October 2019 internship: Department of Pediatric Oncology, IRCCS Istituto Nazionale Tumori, Milan.
From 2020 attending Postgraduate School of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, University of Milan.
From 2024 attending PhD course, Open University, Fondazione IRCCS Istituto Nazionale Tumori, University of Milan.

Poster(s):

• (P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR

• (P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA

• (P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)

• (P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)